Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNVU1-24 (RNA, variant U1 small nuclear 24) is a pseudogene for U1 small nuclear RNA, designated HGNC:48401 and NCBI Gene:106480167[5][7]. It is also known as RNU1-59P, RNA U1 small nuclear 59, pseudogene. The U1 snRNA gene family encodes small nuclear RNAs essential for pre-mRNA splicing, but pseudogenes like RNVU1-24 contain sequence variations that disrupt the canonical functions and generally cannot encode functional proteins or snRNAs[4][5]. Although once considered nonfunctional, some snRNA pseudogenes are transcribed and may have regulatory RNA-based roles, such as acting as decoys for microRNAs or influencing mRNA stability[4][6]. However, for RNVU1-24 specifically, there is no evidence of a major biological function, disease association, or therapeutic relevance[5][7]. It is not recognized as a drug target or biomarker in current molecular medicine. The gene is catalogued as a pseudogene in major databases with no confirmed functional annotations.
No known mechanisms for drugs targeting RNVU1-24. By analogy, pseudogene RNAs can influence gene expression by miRNA sponge/decoy activity, antisense interactions, or competing for regulatory factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, variant U1 small nuclear 24 (RNVU1-24).